BACKGROUND: Disseminated tuberculosis (TB) is a common cause of death among human immunodeficiency virus (HIV)-infected patients in developing countries. Blood culture offers a potential means to diagnose disseminated TB, but optimal blood culture methods have not been studied. METHODS:Two hundred and fifty-eight HIV-infected patients hospitalized in Tanzania with ≥2 weeks fever or cough had diagnostic studies for TB: 3 sputum samples for acid-fast bacilli smear and culture; 40 ml of blood for culture, randomized 1:1 to 40 ml × 1, or 20 ml × 2 collected 12-24 h apart. Blood was processed using automated MB BacT(®) broth and manual Isolator(®) lysis-centrifugation agar. Mortality was assessed at 2 months. RESULTS:TB was confirmed in 83 (32%) of 258 patients: by sputum only in 42 (51%, median CD4 = 72 cells/μl), blood only in 15 (18%, median CD4 = 44 cells/μl), and in sputum and blood in 26 (31%, median CD4 = 12 cells/μl). Blood was positive in 21 (16%) for 40 ml × 1 vs 20 (15%) for 20 ml × 1 (p = 0.83) vs 20 (16%) for 20 ml × 2 (p = 0.97). MB BacT was positive in 31 (76%) and Isolator was positive in 20 (49%) of 41 samples (p = 0.01). The mean colony-forming units/ml was 8 (range 3-14). Twenty-one (51%) patients with disseminated TB died; median survival was 6 days (range 0-58). CONCLUSIONS: Disseminated TB in HIV is characterized by persistent bacteraemia, delayed microbiological detection, and high mortality. Twenty millilitres of blood processed by automated broth is the optimal culture method to detect disseminated TB. Empiric TB therapy is warranted for HIV-infected patients from TB-endemic countries with prolonged cough or fever.
RCT Entities:
BACKGROUND: Disseminated tuberculosis (TB) is a common cause of death among human immunodeficiency virus (HIV)-infectedpatients in developing countries. Blood culture offers a potential means to diagnose disseminated TB, but optimal blood culture methods have not been studied. METHODS: Two hundred and fifty-eight HIV-infectedpatients hospitalized in Tanzania with ≥2 weeks fever or cough had diagnostic studies for TB: 3 sputum samples for acid-fast bacilli smear and culture; 40 ml of blood for culture, randomized 1:1 to 40 ml × 1, or 20 ml × 2 collected 12-24 h apart. Blood was processed using automated MB BacT(®) broth and manual Isolator(®) lysis-centrifugation agar. Mortality was assessed at 2 months. RESULTS: TB was confirmed in 83 (32%) of 258 patients: by sputum only in 42 (51%, median CD4 = 72 cells/μl), blood only in 15 (18%, median CD4 = 44 cells/μl), and in sputum and blood in 26 (31%, median CD4 = 12 cells/μl). Blood was positive in 21 (16%) for 40 ml × 1 vs 20 (15%) for 20 ml × 1 (p = 0.83) vs 20 (16%) for 20 ml × 2 (p = 0.97). MB BacT was positive in 31 (76%) and Isolator was positive in 20 (49%) of 41 samples (p = 0.01). The mean colony-forming units/ml was 8 (range 3-14). Twenty-one (51%) patients with disseminated TB died; median survival was 6 days (range 0-58). CONCLUSIONS: Disseminated TB in HIV is characterized by persistent bacteraemia, delayed microbiological detection, and high mortality. Twenty millilitres of blood processed by automated broth is the optimal culture method to detect disseminated TB. Empiric TB therapy is warranted for HIV-infectedpatients from TB-endemic countries with prolonged cough or fever.
Authors: John A Crump; Marion J Tuohy; Anne B Morrissey; Habib O Ramadhani; Boniface N Njau; Venance P Maro; L Barth Reller; Gary W Procop Journal: J Clin Microbiol Date: 2011-10-26 Impact factor: 5.948
Authors: P B Pavlinac; E M Lokken; J L Walson; B A Richardson; J A Crump; G C John-Stewart Journal: Int J Tuberc Lung Dis Date: 2016-07 Impact factor: 2.373
Authors: John A Crump; Habib O Ramadhani; Anne B Morrissey; Wilbrod Saganda; Mtumwa S Mwako; Lan-Yan Yang; Shein-Chung Chow; Boniface N Njau; Godfrey S Mushi; Venance P Maro; L Barth Reller; John A Bartlett Journal: Clin Infect Dis Date: 2012-04-16 Impact factor: 9.079
Authors: Elizabeth Talbot; Patricia Munseri; Pedro Teixeira; Mecky Matee; Muhammad Bakari; Timothy Lahey; Fordham von Reyn Journal: PLoS One Date: 2012-03-08 Impact factor: 3.240
Authors: Freddie Bwanga; Claudia Disqué; Michael G Lorenz; Vera Allerheiligen; William Worodria; Allan Luyombya; Irene Najjingo; Michael Weizenegger Journal: BMC Infect Dis Date: 2015-02-06 Impact factor: 3.090
Authors: Tania A Thomas; Scott K Heysell; Prashini Moodley; Romualde Montreuil; Xia Ha; Gerald Friedland; Sheila A Bamber; Anthony P Moll; Neel Gandhi; William E Brant; Willem Sturm; Sarita Shah Journal: BMC Infect Dis Date: 2014-01-09 Impact factor: 3.090
Authors: Shevin T Jacob; Patricia B Pavlinac; Lydia Nakiyingi; Patrick Banura; Jared M Baeten; Karen Morgan; Amalia Magaret; Yuka Manabe; Steven J Reynolds; W Conrad Liles; Anna Wald; Moses L Joloba; Harriet Mayanja-Kizza; W Michael Scheld Journal: PLoS One Date: 2013-08-05 Impact factor: 3.240
Authors: Yukari C Manabe; Bareng A S Nonyane; Lydia Nakiyingi; Olive Mbabazi; Gloria Lubega; Maunank Shah; Lawrence H Moulton; Moses Joloba; Jerrold Ellner; Susan E Dorman Journal: PLoS One Date: 2014-07-07 Impact factor: 3.240
Authors: Andrew D Kerkhoff; David A Barr; Charlotte Schutz; Rosie Burton; Mark P Nicol; Stephen D Lawn; Graeme Meintjes Journal: Sci Rep Date: 2017-09-07 Impact factor: 4.379